Blogs

NEXTDC (ASX: NXT) has cut its FY27 guidance after Jemena suspended grid works at its Melbourne M3 data centre, deferring contracted revenue into FY28, while the company pauses uncontracted projects and reviews its capital spending plans.

SomnoMed (ASX: SOM): Jumps 23% From Yearly Low as Europe Reset Tests Growth Story

SomnoMed (ASX: SOM) shares jumped 23% to $0.29 near their yearly low, as the sleep apnoea device maker weighs a European reimbursement reset against North American growth and wider margins after FY26 EBITDA rose 19%.

Overwatch Technologies (ASX: OWL): IPO Puts Maritime Surveillance Growth Prospects in Focus

Overwatch Technologies (ASX: OWL) has raised A$8 million through its IPO to advance its maritime surveillance technology, with future growth depending on government contracts, commercialisation and its ability to convert early customer activity into sustained revenue.

Gulf Stream Energy (ASX: GSE): Directors Put Fresh Cash behind Oil Push

Gulf Stream Energy (ASX: GSE) directors Eduardo Robaina, Joseph Graham and Troy Warrick converted performance rights and joined the October placement at $0.0045, buying roughly 15.9 million shares as the small explorer reports US oil discoveries.

Black Canyon (ASX: BCA): Option Expiry and AGM Put Capital Structure in Focus

Black Canyon (ASX: BCA) has issued new shares following option exercises, recorded the expiry of unexercised options, and outlined key resolutions for its November AGM, including a proposed 10% placement capacity to fund Wandanya Project development.

Alterity Therapeutics (ASX: ATH): New ATH434 Analysis Strengthens Case for Phase 3 Development

Alterity Therapeutics (ASX: ATH) reported an adjusted Phase 2 analysis showing ATH434 slowed functional decline by about 52% versus placebo at Week 52, as the company advances Phase 3 planning and evaluates funding needs.

RemSense Technologies (ASX: REM): Director Options Plan Puts Pay and Dilution in Focus

RemSense Technologies (ASX: REM) will ask shareholders to approve 45 million unlisted options for its three directors at its 30 October AGM, a move that would dilute existing holders by about 15.6% if fully exercised, alongside an auditor appointment.

Dateline Resources (ASX: DTR): Colosseum’s Gold Reserves Offer Significant Upside, but Legal and Development Risks Remain

Dateline Resources (ASX: DTR) holds 100% of Colosseum, with a 573,000oz gold reserve and A$86.0 million cash. An August 2026 court injunction halted activities, creating legal and financing risks. Colosseum is valued at US$380 million to US$727 million.

Norwood Systems (ASX: NOR): Driving Next-Gen Voice AI Solutions with Oversubscribed Note Financing

Norwood Systems (ASX: NOR) raised $695,000 through an oversubscribed convertible note as its OpenSpan Voice AI pilots with Tier-1 telecom operators advance, after FY26 revenue rose 22% to $2.32 million.

Starpharma Holdings (ASX: SPL): Petalion Stake Increase Puts Oncology Pipeline in Focus

Starpharma Holdings (ASX: SPL) has increased its stake in Petalion Therapeutics to 66%, gaining majority ownership of its FAP-targeted oncology program and allocating up to A$5 million to advance drug development and support future partnering opportunities.

Adisyn (ASX: AI1): 10 Million Performance Rights Hand New Graphene Chief a Revenue Test

Adisyn (ASX: AI1) has appointed former Tower Semiconductor COO Ephraim Koltin to lead its graphene subsidiary, with up to 10 million performance rights tied to customer contracts, revenue and share price hurdles that will define how commercial progress is judged.

Eminence Minerals (ASX: EMA): Gold Expansion in Côte d’Ivoire and Rare Earths Progress in Brazil

Eminence Minerals (ASX: EMA) has entered into option agreements to acquire interests in five gold projects in Côte d’Ivoire while advancing rare earth exploration in Brazil, with assay results and shareholder approval for a proposed share issuance among key upcoming milestones.

WhiteHawk (ASX: WHK): Partner-Led Route into Washington's Biggest Tech Buying Channel

WhiteHawk (ASX: WHK) has been picked by Bell Federal Systems to chase U.S. federal work under NASA's SEWP VI contract, giving the cybersecurity firm a partner-led route to market, though no orders or revenue are guaranteed.

Woodside Energy (ASX: WDS): Growth Projects, Dividend Strength and Valuation Outlook

Woodside Energy (ASX: WDS) lifted 1H2026 net profit 27% to US$1.67bn and declared a US57 cent interim dividend. Scarborough LNG is 98% complete, with first cargo targeted for Q4 2026. Valuation is A$27.28 to A$32.24.

Flight Centre (ASX: FLT): Earnings Recovery and Buy-backs Support Upside, but Travel-Sector Risks Remain

Flight Centre’s FY2026 revenue reached A$2.86 billion and net profit A$149 million. Corporate growth and buybacks support recovery, while leisure weakness and geopolitical risks persist. Forecast earnings underpin a valuation range of A$14.88–A$17.36 per share.

Deep Yellow (ASX: DYL): Sell-Off Accelerates After Tumas FID Delay Deepens Funding Concerns

Deep Yellow (ASX: DYL) has withdrawn its Q4 2026 final investment decision target for the Tumas uranium project, citing weak equity markets, while civil works continue and are funded from existing cash reserves.

Cobre (ASX: CBE): $90M Capital Raise and Sierra Atacama Expansion Put Copper Production in Focus

Cobre (ASX: CBE) completed a A$90 million capital raising, increased its stake in Chile’s Sierra Atacama copper project to 62.86%, and outlined staged production expansion plans alongside upcoming board and leadership changes.

Macroeconomic Report Ending 18 October 2026

Macroeconomic Report for the Week Ending 18 October 2026 – Australian Market Outlook

Global markets weighed persistent inflation, uneven growth, and geopolitical risks. Australian shares gained 1.03%, led by Utilities, Health Care, and Consumer Staples, while weaker employment, RBA rate expectations, commodity prices, and China’s trade outlook shaped investor sentiment.

Challenger (ASX: CGF): Daiichi's $11.80 Offer Tests Value of Australia's Retirement Income Leader

Challenger (ASX: CGF) has received a non-binding $11.80 per share takeover proposal from Daiichi Life's Australian arm, arriving alongside record annuity sales, a new funding program and a pending Fidante merger shaping the group's future.

RAS Technology Holdings (ASX: RTH): $1.04 Cash Bid from The PA Reshapes Racing Data

RAS Technology Holdings (ASX: RTH) has agreed a binding all-cash scheme with UK group The PA, offering shareholders a large premium to the last close. Board support, founder backing, conditions and a February 2027 timetable are outlined.

Invictus Energy (ASX: IVZ): Musuma-1 Site Completion Sets Stage for November Drilling Campaign